Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy

Tamás Bitó, I. Földesi, T. Nyári, A. Pál

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aims: We hypothesized that an increased serum insulin level in early pregancy reflects an increased demand on the compensatory capacity of the pregnant woman, and can serve as a predictor of gestational diabetes mellitus (GDM). Methods: A 2-h, 75-g oral glucose tolerance test (OGTT), with fasting and 2-h postprandial serum insulin determination, was performed in 71 pregnant women with one or more risk factors for GDM before gestation week 16. In 64 patients, subsequent OGTTs were performed at gestation weeks 24-28, and in the event of a negative result, at gestation weeks 32-34. Results: Insulin determination at fasting and at 120 min had sensitivities of 69.2% and 92.3%, and specificities of 96.4% and 85.7%, respectively, for the prediction of GDM at gestation weeks 24-28. The sensitivities decreased to 33.3% and 75.0%, respectively, for the prediction of GDM at gestation weeks 32-34. Insulin determination at fasting and at 120 min had positive predictive values of 0.90 and 0.75, respectively, for the prediction of GDM at gestation weeks 32-34. The negative predictive values of fasting and 120-min serum insulin determination at gestation week ≤ 16 were 0.87 and 0.96, respectively, for the prediction of GDM at gestation weeks 24-28. Increased serum insulin levels both at fasting and 120 min before gestation week 16 were very strong predictive factors for GDM by gestation weeks 32-34 with an odds ratio of 16.6 and 13.3, respectively. Conclusions: Serum insulin determination at gestation week ≤ 16 is an easy and reliable method with which to predict GDM in a high-risk group. Despite a negative OGTT, patients with an elevated fasting and/or 120-min serum insulin level at gestation week ≤ 16 should be managed in the same way as those with GDM. Considering the very high negative predictive value of the method, patients with a normal fasting and/or 120-min serum insulin level at gestation week ≤ 16 should undergo an OGTT only at gestation weeks 32-34.

Original languageEnglish
Pages (from-to)1434-1439
Number of pages6
JournalDiabetic Medicine
Volume22
Issue number10
DOIs
Publication statusPublished - Oct 2005

Fingerprint

Gestational Diabetes
Insulin
Pregnancy
Fasting
Glucose Tolerance Test
Serum
Pregnant Women
varespladib methyl

Keywords

  • Diagnosis
  • Gestational diabetes mellitus
  • Insulin
  • Risk factors
  • Screening

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy. / Bitó, Tamás; Földesi, I.; Nyári, T.; Pál, A.

In: Diabetic Medicine, Vol. 22, No. 10, 10.2005, p. 1434-1439.

Research output: Contribution to journalArticle

@article{ee6a7bbf9de84afe80b86cfebfc4c8c1,
title = "Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy",
abstract = "Aims: We hypothesized that an increased serum insulin level in early pregancy reflects an increased demand on the compensatory capacity of the pregnant woman, and can serve as a predictor of gestational diabetes mellitus (GDM). Methods: A 2-h, 75-g oral glucose tolerance test (OGTT), with fasting and 2-h postprandial serum insulin determination, was performed in 71 pregnant women with one or more risk factors for GDM before gestation week 16. In 64 patients, subsequent OGTTs were performed at gestation weeks 24-28, and in the event of a negative result, at gestation weeks 32-34. Results: Insulin determination at fasting and at 120 min had sensitivities of 69.2{\%} and 92.3{\%}, and specificities of 96.4{\%} and 85.7{\%}, respectively, for the prediction of GDM at gestation weeks 24-28. The sensitivities decreased to 33.3{\%} and 75.0{\%}, respectively, for the prediction of GDM at gestation weeks 32-34. Insulin determination at fasting and at 120 min had positive predictive values of 0.90 and 0.75, respectively, for the prediction of GDM at gestation weeks 32-34. The negative predictive values of fasting and 120-min serum insulin determination at gestation week ≤ 16 were 0.87 and 0.96, respectively, for the prediction of GDM at gestation weeks 24-28. Increased serum insulin levels both at fasting and 120 min before gestation week 16 were very strong predictive factors for GDM by gestation weeks 32-34 with an odds ratio of 16.6 and 13.3, respectively. Conclusions: Serum insulin determination at gestation week ≤ 16 is an easy and reliable method with which to predict GDM in a high-risk group. Despite a negative OGTT, patients with an elevated fasting and/or 120-min serum insulin level at gestation week ≤ 16 should be managed in the same way as those with GDM. Considering the very high negative predictive value of the method, patients with a normal fasting and/or 120-min serum insulin level at gestation week ≤ 16 should undergo an OGTT only at gestation weeks 32-34.",
keywords = "Diagnosis, Gestational diabetes mellitus, Insulin, Risk factors, Screening",
author = "Tam{\'a}s Bit{\'o} and I. F{\"o}ldesi and T. Ny{\'a}ri and A. P{\'a}l",
year = "2005",
month = "10",
doi = "10.1111/j.1464-5491.2005.01634.x",
language = "English",
volume = "22",
pages = "1434--1439",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy

AU - Bitó, Tamás

AU - Földesi, I.

AU - Nyári, T.

AU - Pál, A.

PY - 2005/10

Y1 - 2005/10

N2 - Aims: We hypothesized that an increased serum insulin level in early pregancy reflects an increased demand on the compensatory capacity of the pregnant woman, and can serve as a predictor of gestational diabetes mellitus (GDM). Methods: A 2-h, 75-g oral glucose tolerance test (OGTT), with fasting and 2-h postprandial serum insulin determination, was performed in 71 pregnant women with one or more risk factors for GDM before gestation week 16. In 64 patients, subsequent OGTTs were performed at gestation weeks 24-28, and in the event of a negative result, at gestation weeks 32-34. Results: Insulin determination at fasting and at 120 min had sensitivities of 69.2% and 92.3%, and specificities of 96.4% and 85.7%, respectively, for the prediction of GDM at gestation weeks 24-28. The sensitivities decreased to 33.3% and 75.0%, respectively, for the prediction of GDM at gestation weeks 32-34. Insulin determination at fasting and at 120 min had positive predictive values of 0.90 and 0.75, respectively, for the prediction of GDM at gestation weeks 32-34. The negative predictive values of fasting and 120-min serum insulin determination at gestation week ≤ 16 were 0.87 and 0.96, respectively, for the prediction of GDM at gestation weeks 24-28. Increased serum insulin levels both at fasting and 120 min before gestation week 16 were very strong predictive factors for GDM by gestation weeks 32-34 with an odds ratio of 16.6 and 13.3, respectively. Conclusions: Serum insulin determination at gestation week ≤ 16 is an easy and reliable method with which to predict GDM in a high-risk group. Despite a negative OGTT, patients with an elevated fasting and/or 120-min serum insulin level at gestation week ≤ 16 should be managed in the same way as those with GDM. Considering the very high negative predictive value of the method, patients with a normal fasting and/or 120-min serum insulin level at gestation week ≤ 16 should undergo an OGTT only at gestation weeks 32-34.

AB - Aims: We hypothesized that an increased serum insulin level in early pregancy reflects an increased demand on the compensatory capacity of the pregnant woman, and can serve as a predictor of gestational diabetes mellitus (GDM). Methods: A 2-h, 75-g oral glucose tolerance test (OGTT), with fasting and 2-h postprandial serum insulin determination, was performed in 71 pregnant women with one or more risk factors for GDM before gestation week 16. In 64 patients, subsequent OGTTs were performed at gestation weeks 24-28, and in the event of a negative result, at gestation weeks 32-34. Results: Insulin determination at fasting and at 120 min had sensitivities of 69.2% and 92.3%, and specificities of 96.4% and 85.7%, respectively, for the prediction of GDM at gestation weeks 24-28. The sensitivities decreased to 33.3% and 75.0%, respectively, for the prediction of GDM at gestation weeks 32-34. Insulin determination at fasting and at 120 min had positive predictive values of 0.90 and 0.75, respectively, for the prediction of GDM at gestation weeks 32-34. The negative predictive values of fasting and 120-min serum insulin determination at gestation week ≤ 16 were 0.87 and 0.96, respectively, for the prediction of GDM at gestation weeks 24-28. Increased serum insulin levels both at fasting and 120 min before gestation week 16 were very strong predictive factors for GDM by gestation weeks 32-34 with an odds ratio of 16.6 and 13.3, respectively. Conclusions: Serum insulin determination at gestation week ≤ 16 is an easy and reliable method with which to predict GDM in a high-risk group. Despite a negative OGTT, patients with an elevated fasting and/or 120-min serum insulin level at gestation week ≤ 16 should be managed in the same way as those with GDM. Considering the very high negative predictive value of the method, patients with a normal fasting and/or 120-min serum insulin level at gestation week ≤ 16 should undergo an OGTT only at gestation weeks 32-34.

KW - Diagnosis

KW - Gestational diabetes mellitus

KW - Insulin

KW - Risk factors

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=25844483761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844483761&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2005.01634.x

DO - 10.1111/j.1464-5491.2005.01634.x

M3 - Article

C2 - 16176208

AN - SCOPUS:25844483761

VL - 22

SP - 1434

EP - 1439

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 10

ER -